A report on “The Global 3D Cell Culture Market” published by Allied Market Research states that the 3D cell culture garnered $765 million in 2015 and is expected to accrue a sum of $4,691 million by 2022, growing at a CAGR of 29.4% from 2016 to 2022.
A 3D cell structure refers to an in vitro process where cells are grown in an environment which is artificially created. Bearing a close resemblance to the structure and functioning of the native tissues, the environment lets biological cells to grow, reproduce, and migrate.
The 3D cell culture market is driven by factors such as growing demand for organ transplantation, rise in prevalence of cancer, rise in investments in R&D activities, the benefits offered by 3D culture techniques over 2D culture techniques, and stringent regulations against use of animal models for various pharmaceutical and diagnostic tests. In addition, the launch of novel products due to partnerships between companies, hospitals, and academic institutions are driving the market growth. However, the industry growth is hampered by a dearth of skilled professionals and budget restrictions for research related activities. On the other hand, advancements in technology such as development of improved scaffold-based & scaffold-free products are likely to offer lucrative opportunities for the industry growth.
Among the product types, the micro-chips segment is likely to grow at the highest rate during the analysis period. The other types discussed in the study are scaffold-based platforms (macro-porous, micro-porous, nano-porous, and solid scaffolds), scaffold-free platforms, gels, bioreactors, and services.
Among the applications discussed in the report, cancer research is expected to lead the global 3D cell culture market in terms of revenue during the study period. This is because the nature of the cancer cells grown in 3D culture is similar to the cells that grow in vivo, allowing researchers to study various features of a tumor such as hypoxia, dormancy, and anti-apoptotic behavior. R&D activities in oncology have grown fast due to the wide benefits offered by 3D cell culture.
Among the regions, North America was the largest market for 3D cell culture in 2015, capturing nearly two-fifths of the global market share. The market is also likely to maintain its dominance throughout the forecast period, owing to advancements in various healthcare applications such as cancer and tissue engineering. For instance, in 2016, a Canadian scientist developed a miniature lattice structure called AngioChip that is expected to find use in the growth of human tissues outside the body. The technology is used to test the effects of drugs on human tissues.
The major companies operating in the market include 3D Biotek, LLC, Advanced Biomatrix, Inc., Becton, Dickinson, and Company, Corning Incorporated, Kuraray Co., Ltd., Lonza Group Ltd., Merck & Co., Inc., Synthecon, Incorporated, Thermo Fisher Scientific Inc., and VWR Corporation.
Key Benefits For Stakeholders
- This report entails a detailed quantitative analysis of the current and future trends from 2014 to 2022, which helps to identify the prevailing 3D cell culture market opportunities.
- The market estimations are based on high-end analysis of the key developments.
- The market scenario is comprehensively analyzed with respect to the product type, applications, end users, and geography to assist in strategic business planning.
- The key market players within the 3D cell culture market are profiled in this report and their strategies are thoroughly analyzed, which help to understand the competitive market scenario.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060